Literature DB >> 28281892

Self-defense against Bacillus anthracis toxins: Is P-selectin the key?

John D Campbell1.   

Abstract

Entities:  

Keywords:  P-selectin; anthrax; lethal toxin; post-exposure-prophylaxis

Mesh：

Substances：

Year:  2017        PMID： 28281892      PMCID： PMC5711421          DOI： 10.1080/21505594.2017.1304344

Source DB:  PubMed          Journal:  Virulence        ISSN： 2150-5594            Impact factor:   5.882


× No keyword cloud information.
  20 in total

1.  Pro-coagulant state resulting from high levels of soluble P-selectin in blood.

Authors:  P André; D Hartwell; I Hrachovinová; S Saffaripour; D D Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 2.  Correlates of protection induced by vaccination.

Authors:  Stanley A Plotkin
Journal:  Clin Vaccine Immunol       Date:  2010-05-12

3.  The Sverdlovsk anthrax outbreak of 1979.

Authors:  M Meselson; J Guillemin; M Hugh-Jones; A Langmuir; I Popova; A Shelokov; O Yampolskaya
Journal:  Science       Date:  1994-11-18       Impact factor: 47.728

4.  Soluble P-selectin rescues mice from anthrax lethal toxin-induced mortality through PSGL-1 pathway-mediated correction of hemostasis.

Authors:  Der-Shan Sun; Yao-Wen Chang; Jyh-Hwa Kau; Hsin-Hsien Huang; Pei-Hsun Ho; Yin-Jeh Tzeng; Hsin-Hou Chang
Journal:  Virulence       Date:  2017-01-19       Impact factor: 5.882

Review 5.  Role of P-selectin and PSGL-1 in coagulation and thrombosis.

Authors:  Erik R Vandendries; Barbara C Furie; Bruce Furie
Journal:  Thromb Haemost       Date:  2004-09       Impact factor: 5.249

6.  Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A.

Authors:  Ingrid Hrachovinová; Beatrice Cambien; Ali Hafezi-Moghadam; János Kappelmayer; Raymond T Camphausen; Angela Widom; Lijun Xia; Haig H Kazazian; Robert G Schaub; Rodger P McEver; Denisa D Wagner
Journal:  Nat Med       Date:  2003-07-13       Impact factor: 53.440

Review 7.  Information on which to base assessments of risk from environments contaminated with anthrax spores.

Authors:  A Watson; D Keir
Journal:  Epidemiol Infect       Date:  1994-12       Impact factor: 2.451

Review 8.  US Food and Drug Administration approval of ciprofloxacin hydrochloride for management of postexposure inhalational anthrax.

Authors:  Andrea Meyerhoff; Renata Albrecht; Joette M Meyer; Peter Dionne; Karen Higgins; Dianne Murphy
Journal:  Clin Infect Dis       Date:  2004-07-08       Impact factor: 9.079

Review 9.  Anthrax: an update.

Authors:  S M Kamal; A K M M Rashid; M A Bakar; M A Ahad
Journal:  Asian Pac J Trop Biomed       Date:  2011-12

10.  Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States.

Authors:  J A Jernigan; D S Stephens; D A Ashford; C Omenaca; M S Topiel; M Galbraith; M Tapper; T L Fisk; S Zaki; T Popovic; R F Meyer; C P Quinn; S A Harper; S K Fridkin; J J Sejvar; C W Shepard; M McConnell; J Guarner; W J Shieh; J M Malecki; J L Gerberding; J M Hughes; B A Perkins
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.